Top Markets
Coin of the day
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

HTGM
Classement en actions #28761
Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences... Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences company dedicated to advancing precision medicine. They provide a comprehensive suite of products, including specialized instruments, assay kit consumables, and software solutions, all designed to automate sample processing and accurately profile various molecular targets. Their extensive portfolio features numerous molecular profiling panels, such as the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, HTG EdgeSeq miRNA whole-transcriptome assay, HTG EdgeSeq DLBCL cell of origin assay (available in both EU and non-EU versions), HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq ALKPlus assay EU, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG immune response panel, and HTG mouse mRNA tumor response panel. The company directly distributes its instruments and consumables across the United States and Europe, while utilizing distributors for other international markets and specific European regions. Their diverse clientele includes biopharmaceutical companies, academic research centers, and molecular testing laboratories. Additionally, HTG Molecular Diagnostics, Inc. maintains a governing agreement with QIAGEN Manchester Limited. The company was founded in 1997 as HTG, Inc., and officially changed its name to HTG Molecular Diagnostics, Inc. in March 2011.
Prix de l'action
$0.48
Dernière synchronisation: 2023-06-14
Capitalisation boursière
$24.79M
Changement (1 jour)
-20.00%
Changement (1 an)
0.00%
Pays
US
Échange HTG Molecular Diagnostics, Inc. (HTGM)

Catégorie

Le prix HTGM avec la capitalisation boursière de B
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.
HTGM
$0.48
Capitalisation boursière de HTG Molecular Diagnostics, Inc.(HTGM)
Capitalisation boursière: $24.79M
En August 2026, HTG Molecular Diagnostics, Inc. a une capitalisation boursière de $24.79M. Cela fait de HTG Molecular Diagnostics, Inc. la 28761st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de HTG Molecular Diagnostics, Inc. du 2015 au 2026
HTGM par rapport au top 5 des plus populaires stocks
Prix pour HTGM L’actif B La capitalisation boursière de B Résultats
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.
$102,798 $24.79M
$5.310T +21,416,069.96%
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.
$89,667.35 $24.79M
$4.632T +18,680,598.13%
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.
$80,148.56 $24.79M
$4.140T +16,697,517.20%
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.
$69,591.26 $24.79M
$3.595T +14,498,079.58%
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.
$55,071.87 $24.79M
$2.845T +11,473,205.48%